Research News #1
What is an MS label?
Q&A 142: Epsilon toxin and MS
Should I be worried about measles?
Q&A 141: neutropaenia on ocrelizumab
Tolebrutinib treatment algorithm 2.0
Proposed tolebrutinib treatment algorithm
Q&A 140 - therapeutic inertia
Conscious or not
Male and female-specific MS care pathways
Gender inequality in MS care
Q&A 139 - tolebrutinib and the FDA
Necessary, but insufficient
Q&A 137: Menstrual problems and MS
New MS subtypes or not?
Q&A 135: Tooth loss and periodontal disease in MS
